Fundraising Fox
Northsea Therapeutics
8 known investors
Find your way into Northsea Therapeutics
Sign up to see every warm intro you have to Northsea Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Northsea Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NorthSea Therapeutics is a clinical-stage biopharmaceutical company developing oral fatty acid-derived therapies for liver and metabolic diseases, including intestinal failure-associated liver disease (IFALD), severe hypertriglyceridemia, and MASH. Its programs target patient populations with limited existing treatment options.
Investors · 8
How we know: New Science Ventures's portfolio page · the company's own site · the VCSheet dataset · Not right? Tell us
How we know: the company's own site · the VCSheet dataset · Not right? Tell us
How we know: Ysios Capital's portfolio page · the company's own site · the VCSheet dataset · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: BioGeneration Ventures's portfolio page · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the VCSheet dataset · sofinnova.com · Not right? Tell us
How we know: a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
Frequently asked questions
- What does Northsea Therapeutics do?
- NorthSea Therapeutics is a clinical-stage biopharmaceutical company developing oral fatty acid-derived therapies for liver and metabolic diseases, including intestinal failure-associated liver disease (IFALD), severe hypertriglyceridemia, and MASH. Its programs target patient populations with limited existing treatment options.
- Who are Northsea Therapeutics's investors?
- Northsea Therapeutics's investors include New Science Ventures, venBio Partners, Ysios Capital, BGV, Novo Holdings, BioGeneration Ventures, Sofinnova Ventures, Forbion.